Compare Stocks

4 / 10
Try these comparisons:

Stock Comparison

IRIX vs ISRG vs SYK vs HOLX

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
IRIX
IRIDEX Corporation

Medical - Devices

HealthcareNASDAQ • US
Market Cap$18M
5Y Perf.-42.8%
ISRG
Intuitive Surgical, Inc.

Medical - Instruments & Supplies

HealthcareNASDAQ • US
Market Cap$159.85B
5Y Perf.+132.8%
SYK
Stryker Corporation

Medical - Devices

HealthcareNYSE • US
Market Cap$109.33B
5Y Perf.+45.8%
HOLX
Hologic, Inc.

Medical - Instruments & Supplies

HealthcareNASDAQ • US
Market Cap$16.97B
5Y Perf.+42.6%

IRIX vs ISRG vs SYK vs HOLX — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
IRIX logoIRIX
ISRG logoISRG
SYK logoSYK
HOLX logoHOLX
IndustryMedical - DevicesMedical - Instruments & SuppliesMedical - DevicesMedical - Instruments & Supplies
Market Cap$18M$159.85B$109.33B$16.97B
Revenue (TTM)$51M$10.58B$25.12B$4.13B
Net Income (TTM)$-5M$2.98B$3.25B$544M
Gross Margin38.0%66.3%63.5%52.8%
Operating Margin-6.0%30.5%22.4%17.5%
Forward P/E43.3x19.1x17.2x
Total Debt$5M$303M$14.86B$2.63B
Cash & Equiv.$2M$3.37B$4.01B$1.96B

IRIX vs ISRG vs SYK vs HOLXLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

IRIX
ISRG
SYK
HOLX
StockMay 20May 26Return
IRIDEX Corporation (IRIX)10057.2-42.8%
Intuitive Surgical,… (ISRG)100232.8+132.8%
Stryker Corporation (SYK)100145.8+45.8%
Hologic, Inc. (HOLX)100142.6+42.6%

Price return only. Dividends and distributions are not included.

Quick Verdict: IRIX vs ISRG vs SYK vs HOLX

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: ISRG and HOLX are tied at the top with 3 categories each — the right choice depends on your priorities. Hologic, Inc. is the stronger pick specifically for valuation and capital efficiency and capital preservation and lower volatility. SYK also leads in specific categories worth noting. As sector peers, any of these can serve as alternatives in the same allocation.
IRIX
IRIDEX Corporation
The Secondary Option

IRIX lags the leaders in this set but could rank higher in a more targeted comparison.

Best for: healthcare exposure
ISRG
Intuitive Surgical, Inc.
The Growth Play

ISRG carries the broadest edge in this set and is the clearest fit for growth exposure and long-term compounding.

  • Rev growth 20.5%, EPS growth 22.6%, 3Y rev CAGR 17.4%
  • 5.5% 10Y total return vs SYK's 179.2%
  • 20.5% revenue growth vs IRIX's -6.2%
  • 28.2% margin vs IRIX's -10.0%
Best for: growth exposure and long-term compounding
SYK
Stryker Corporation
The Value Pick

SYK is the clearest fit if your priority is valuation efficiency.

  • PEG 1.28 vs ISRG's 1.99
  • 1.2% yield; 34-year raise streak; the other 3 pay no meaningful dividend
Best for: valuation efficiency
HOLX
Hologic, Inc.
The Income Pick

HOLX is the #2 pick in this set and the best alternative if income & stability and sleep-well-at-night is your priority.

  • beta 0.45
  • Lower volatility, beta 0.45, Low D/E 52.0%, current ratio 3.75x
  • Beta 0.45, current ratio 3.75x
  • Lower P/E (17.2x vs 43.3x)
Best for: income & stability and sleep-well-at-night
See the full category breakdown
CategoryWinnerWhy
GrowthISRG logoISRG20.5% revenue growth vs IRIX's -6.2%
ValueHOLX logoHOLXLower P/E (17.2x vs 43.3x)
Quality / MarginsISRG logoISRG28.2% margin vs IRIX's -10.0%
Stability / SafetyHOLX logoHOLXBeta 0.45 vs IRIX's 1.16, lower leverage
DividendsSYK logoSYK1.2% yield; 34-year raise streak; the other 3 pay no meaningful dividend
Momentum (1Y)HOLX logoHOLX+35.3% vs SYK's -24.5%
Efficiency (ROA)ISRG logoISRG14.8% ROA vs IRIX's -17.9%, ROIC 15.0% vs -129.9%

IRIX vs ISRG vs SYK vs HOLX — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

IRIXIRIDEX Corporation
FY 2024
Retina
57.2%$28M
Cyclo G Six
26.1%$13M
Product and Service, Other
16.7%$8M
ISRGIntuitive Surgical, Inc.
FY 2025
Instruments and Accessories
59.8%$6.0B
Systems
24.6%$2.5B
Services
15.6%$1.6B
SYKStryker Corporation
FY 2025
MedSurg
62.3%$15.6B
Orthopaedics
37.7%$9.5B
HOLXHologic, Inc.
FY 2025
Diagnostics
44.6%$1.8B
Breast Health
36.2%$1.5B
Gyn Surgical
16.6%$680M
Skeletal Health
2.7%$109M

IRIX vs ISRG vs SYK vs HOLX — Financial Metrics

Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLISRGLAGGINGSYK

Income & Cash Flow (Last 12 Months)

ISRG leads this category, winning 5 of 6 comparable metrics.

SYK is the larger business by revenue, generating $25.1B annually — 495.9x IRIX's $51M. ISRG is the more profitable business, keeping 28.2% of every revenue dollar as net income compared to IRIX's -10.0%. On growth, ISRG holds the edge at +23.0% YoY revenue growth, suggesting stronger near-term business momentum.

MetricIRIX logoIRIXIRIDEX CorporationISRG logoISRGIntuitive Surgica…SYK logoSYKStryker Corporati…HOLX logoHOLXHologic, Inc.
RevenueTrailing 12 months$51M$10.6B$25.1B$4.1B
EBITDAEarnings before interest/tax-$2M$3.8B$6.3B$974M
Net IncomeAfter-tax profit-$5M$3.0B$3.2B$544M
Free Cash FlowCash after capex-$3M$2.8B$4.3B$1000M
Gross MarginGross profit ÷ Revenue+38.0%+66.3%+63.5%+52.8%
Operating MarginEBIT ÷ Revenue-6.0%+30.5%+22.4%+17.5%
Net MarginNet income ÷ Revenue-10.0%+28.2%+12.9%+13.2%
FCF MarginFCF ÷ Revenue-5.6%+26.8%+17.1%+24.2%
Rev. Growth (YoY)Latest quarter vs prior year+7.8%+23.0%+11.4%+2.5%
EPS Growth (YoY)Latest quarter vs prior year+25.0%+18.8%+56.0%-9.2%
ISRG leads this category, winning 5 of 6 comparable metrics.

Valuation Metrics

HOLX leads this category, winning 4 of 7 comparable metrics.

At 30.5x trailing earnings, HOLX trades at a 47% valuation discount to ISRG's 57.2x P/E. Adjusting for growth (PEG ratio), SYK offers better value at 2.29x vs ISRG's 2.63x — a lower PEG means you pay less per unit of expected earnings growth.

MetricIRIX logoIRIXIRIDEX CorporationISRG logoISRGIntuitive Surgica…SYK logoSYKStryker Corporati…HOLX logoHOLXHologic, Inc.
Market CapShares × price$18M$159.8B$109.3B$17.0B
Enterprise ValueMkt cap + debt − cash$20M$156.8B$120.2B$17.6B
Trailing P/EPrice ÷ TTM EPS-1.91x57.19x33.98x30.53x
Forward P/EPrice ÷ next-FY EPS est.43.35x19.06x17.21x
PEG RatioP/E ÷ EPS growth rate2.63x2.29x
EV / EBITDAEnterprise value multiple43.28x19.76x17.39x
Price / SalesMarket cap ÷ Revenue0.36x15.88x4.35x4.14x
Price / BookPrice ÷ Book value/share8.07x9.10x4.87x3.43x
Price / FCFMarket cap ÷ FCF64.18x25.53x18.44x
HOLX leads this category, winning 4 of 7 comparable metrics.

Profitability & Efficiency

ISRG leads this category, winning 6 of 9 comparable metrics.

ISRG delivers a 16.9% return on equity — every $100 of shareholder capital generates $17 in annual profit, vs $-109 for IRIX. ISRG carries lower financial leverage with a 0.02x debt-to-equity ratio, signaling a more conservative balance sheet compared to IRIX's 2.21x. On the Piotroski fundamental quality scale (0–9), HOLX scores 7/9 vs IRIX's 2/9, reflecting strong financial health.

MetricIRIX logoIRIXIRIDEX CorporationISRG logoISRGIntuitive Surgica…SYK logoSYKStryker Corporati…HOLX logoHOLXHologic, Inc.
ROE (TTM)Return on equity-108.7%+16.9%+15.0%+11.0%
ROA (TTM)Return on assets-17.9%+14.8%+6.9%+6.1%
ROICReturn on invested capital-129.9%+15.0%+11.4%+9.4%
ROCEReturn on capital employed-48.8%+16.5%+13.0%+8.8%
Piotroski ScoreFundamental quality 0–92667
Debt / EquityFinancial leverage2.21x0.02x0.66x0.52x
Net DebtTotal debt minus cash$2M-$3.1B$10.8B$667M
Cash & Equiv.Liquid assets$2M$3.4B$4.0B$2.0B
Total DebtShort + long-term debt$5M$303M$14.9B$2.6B
Interest CoverageEBIT ÷ Interest expense6.72x8.00x
ISRG leads this category, winning 6 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

ISRG leads this category, winning 4 of 6 comparable metrics.

A $10,000 investment in ISRG five years ago would be worth $16,174 today (with dividends reinvested), compared to $1,377 for IRIX. Over the past 12 months, HOLX leads with a +35.3% total return vs SYK's -24.5%. The 3-year compound annual growth rate (CAGR) favors ISRG at 14.1% vs IRIX's -23.2% — a key indicator of consistent wealth creation.

MetricIRIX logoIRIXIRIDEX CorporationISRG logoISRGIntuitive Surgica…SYK logoSYKStryker Corporati…HOLX logoHOLXHologic, Inc.
YTD ReturnYear-to-date-12.0%-19.9%-17.8%+1.9%
1-Year ReturnPast 12 months-9.6%-16.4%-24.5%+35.3%
3-Year ReturnCumulative with dividends-54.6%+48.5%+2.4%-8.5%
5-Year ReturnCumulative with dividends-86.2%+61.7%+17.5%+16.8%
10-Year ReturnCumulative with dividends-90.8%+549.2%+179.2%+124.3%
CAGR (3Y)Annualised 3-year return-23.2%+14.1%+0.8%-2.9%
ISRG leads this category, winning 4 of 6 comparable metrics.

Risk & Volatility

HOLX leads this category, winning 2 of 2 comparable metrics.

HOLX is the less volatile stock with a 0.45 beta — it tends to amplify market swings less than IRIX's 1.16 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. HOLX currently trades 100.0% from its 52-week high vs IRIX's 62.4% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricIRIX logoIRIXIRIDEX CorporationISRG logoISRGIntuitive Surgica…SYK logoSYKStryker Corporati…HOLX logoHOLXHologic, Inc.
Beta (5Y)Sensitivity to S&P 5001.16x1.00x0.52x0.45x
52-Week HighHighest price in past year$1.65$603.88$404.87$76.04
52-Week LowLowest price in past year$0.87$427.84$284.97$53.62
% of 52W HighCurrent price vs 52-week peak+62.4%+74.5%+70.5%+100.0%
RSI (14)Momentum oscillator 0–10041.643.626.669.1
Avg Volume (50D)Average daily shares traded124K1.8M2.1M10.3M
HOLX leads this category, winning 2 of 2 comparable metrics.

Analyst Outlook

Insufficient data to determine a leader in this category.

Analyst consensus: ISRG as "Buy", SYK as "Buy", HOLX as "Hold". Consensus price targets imply 38.3% upside for ISRG (target: $623) vs 3.9% for HOLX (target: $79). SYK is the only dividend payer here at 1.18% yield — a key consideration for income-focused portfolios.

MetricIRIX logoIRIXIRIDEX CorporationISRG logoISRGIntuitive Surgica…SYK logoSYKStryker Corporati…HOLX logoHOLXHologic, Inc.
Analyst RatingConsensus buy/hold/sellBuyBuyHold
Price TargetConsensus 12-month target$622.60$389.62$79.00
# AnalystsCovering analysts555042
Dividend YieldAnnual dividend ÷ price+1.2%
Dividend StreakConsecutive years of raises34
Dividend / ShareAnnual DPS$3.36
Buyback YieldShare repurchases ÷ mkt cap0.0%+1.4%0.0%+4.4%
Insufficient data to determine a leader in this category.
Key Takeaway

ISRG leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). HOLX leads in 2 (Valuation Metrics, Risk & Volatility).

Best OverallIntuitive Surgical, Inc. (ISRG)Leads 3 of 6 categories
Loading custom metrics...

IRIX vs ISRG vs SYK vs HOLX: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is IRIX or ISRG or SYK or HOLX a better buy right now?

For growth investors, Intuitive Surgical, Inc.

(ISRG) is the stronger pick with 20. 5% revenue growth year-over-year, versus -6. 2% for IRIDEX Corporation (IRIX). Hologic, Inc. (HOLX) offers the better valuation at 30. 5x trailing P/E (17. 2x forward), making it the more compelling value choice. Analysts rate Intuitive Surgical, Inc. (ISRG) a "Buy" — based on 55 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — IRIX or ISRG or SYK or HOLX?

On trailing P/E, Hologic, Inc.

(HOLX) is the cheapest at 30. 5x versus Intuitive Surgical, Inc. at 57. 2x. On forward P/E, Hologic, Inc. is actually cheaper at 17. 2x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Stryker Corporation wins at 1. 28x versus Intuitive Surgical, Inc. 's 1. 99x — a reasonable growth-adjusted valuation.

03

Which is the better long-term investment — IRIX or ISRG or SYK or HOLX?

Over the past 5 years, Intuitive Surgical, Inc.

(ISRG) delivered a total return of +61. 7%, compared to -86. 2% for IRIDEX Corporation (IRIX). Over 10 years, the gap is even starker: ISRG returned +549. 2% versus IRIX's -90. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — IRIX or ISRG or SYK or HOLX?

By beta (market sensitivity over 5 years), Hologic, Inc.

(HOLX) is the lower-risk stock at 0. 45β versus IRIDEX Corporation's 1. 16β — meaning IRIX is approximately 155% more volatile than HOLX relative to the S&P 500. On balance sheet safety, Intuitive Surgical, Inc. (ISRG) carries a lower debt/equity ratio of 2% versus 2% for IRIDEX Corporation — giving it more financial flexibility in a downturn.

05

Which is growing faster — IRIX or ISRG or SYK or HOLX?

By revenue growth (latest reported year), Intuitive Surgical, Inc.

(ISRG) is pulling ahead at 20. 5% versus -6. 2% for IRIDEX Corporation (IRIX). On earnings-per-share growth, the picture is similar: Intuitive Surgical, Inc. grew EPS 22. 6% year-over-year, compared to -25. 0% for Hologic, Inc.. Over a 3-year CAGR, ISRG leads at 17. 4% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — IRIX or ISRG or SYK or HOLX?

Intuitive Surgical, Inc.

(ISRG) is the more profitable company, earning 28. 4% net margin versus -18. 3% for IRIDEX Corporation — meaning it keeps 28. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ISRG leads at 29. 3% versus -17. 1% for IRIX. At the gross margin level — before operating expenses — ISRG leads at 66. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is IRIX or ISRG or SYK or HOLX more undervalued right now?

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, Stryker Corporation (SYK) is the more undervalued stock at a PEG of 1. 28x versus Intuitive Surgical, Inc. 's 1. 99x. A PEG below 1. 5 suggests fair-to-attractive pricing relative to expected growth. On forward earnings alone, Hologic, Inc. (HOLX) trades at 17. 2x forward P/E versus 43. 3x for Intuitive Surgical, Inc. — 26. 1x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for ISRG: 38. 3% to $622. 60.

08

Which pays a better dividend — IRIX or ISRG or SYK or HOLX?

In this comparison, SYK (1.

2% yield) pays a dividend. IRIX, ISRG, HOLX do not pay a meaningful dividend and should not be held primarily for income.

09

Is IRIX or ISRG or SYK or HOLX better for a retirement portfolio?

For long-horizon retirement investors, Stryker Corporation (SYK) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

52), 1. 2% yield, +179. 2% 10Y return). Both have compounded well over 10 years (SYK: +179. 2%, IRIX: -90. 8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between IRIX and ISRG and SYK and HOLX?

Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: IRIX is a small-cap quality compounder stock; ISRG is a mid-cap high-growth stock; SYK is a mid-cap quality compounder stock; HOLX is a mid-cap quality compounder stock. SYK pays a dividend while IRIX, ISRG, HOLX do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.

Stocks Like

IRIX

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Gross Margin > 22%
Run This Screen
Stocks Like

ISRG

High-Growth Quality Leader

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 11%
  • Net Margin > 16%
Run This Screen
Stocks Like

SYK

Stable Dividend Mega-Cap

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Net Margin > 7%
Run This Screen
Stocks Like

HOLX

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
  • Net Margin > 7%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform IRIX and ISRG and SYK and HOLX on the metrics below

Revenue Growth>
%
(IRIX: 7.8% · ISRG: 23.0%)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.